BC Data

BC Data, from BC Platforms, is a global real-world data solution designed to help life sciences and healthcare organizations transform fragmented, multi-modal data into harmonized, research-ready datasets. Built on an AI-enabled federated architecture and a global data partner network spanning 35+ countries, BC Data accelerates discovery and evidence generation across the full product lifecycle — from early research through clinical development, market access, and post-launch studies.

With access to more than 187 million patient lives across Europe, Japan, APAC, and the Americas — with over 90% of patients sourced from outside the United States — BC Data connects hospitals, research organizations, and biobanks through a single federated ecosystem. The network includes 150+ longstanding data partners across urban, suburban, and rural settings, ensuring diverse, high-quality, and rapidly accessible datasets for a wide range of advanced use cases.

Data Coverage and Sources

• Multi-modal data spanning electronic medical records (EMRs), imaging, lab values, genomics and multi-omics, disease-specific outcomes, health and lifestyle data, and biobank data
• Both structured and unstructured real-world data (RWD) harmonized into analysis-ready datasets
• Global coverage across EMEA, APAC, and the Americas, with more than 90% of accessible patient lives from outside the US
• Ex-US clinical data that meets international regulatory standards for quality, ethics, and scientific validity to support regulatory submissions
• Customized data access tailored to specific research focus, geography, and study design

Key Therapy Areas

• Oncology and hematology
• Immunology
• Neurology
• Cardiology
• Rare diseases

Advanced Use Cases Supported

• Discovery and clinical R&D: Accelerate feasibility studies, cohort identification, and chart reviews using harmonized, patient-level data
• Market access and commercialization: Generate real-world evidence to inform market access strategies, support payer discussions, and power post-launch studies
• Digital twin and synthetic data: Use advanced analytics and AI modeling to simulate clinical outcomes, fill data gaps, and generate predictive insights
• Custom-curated datasets: Build or access bespoke datasets tailored to specific geographies, therapeutic areas, or population focuses

Data Harmonization and Technology

• BC Unify, BC Platforms' AI-driven data mastering platform, ingests, harmonizes, anonymizes, and standardizes structured and unstructured multi-modal data from diverse sources
• Every dataset is cleaned, made compliant, and rendered research-ready through a single trusted data foundation
• A trusted research environment (TRE) — BC Mosaic — provides secure access and collaboration without technical complexity, integrating with existing analytical tools and workflows
• Flexible deployment options including direct data delivery, trusted research environments (TREs), cloud, and federated architectures

Proven Impact

• Harmonized secondary real-world datasets from nine EU and APAC countries for a top-10 pharma company to support cross-country analysis of treatment patterns and biomarker testing in oncology
• Integrated phenotype, omics, demographic, and clinical data within a federated environment for NHS Southampton, accelerating cohort recruitment by 60% across 100 institutions for vaccine trials
• Mapped treatment pathways and harmonized multi-country datasets from 12 sites across the US, EU, UK, and Japan for a top-20 pharma company, delivering a regulatory-grade CDISC dataset for a rare disease submission
• Standardized longitudinal data from 1,000 NSCLC patients across 12 sites in the UK, Germany, and Spain to support payer discussions and HTA evidence generation
• Provided multi-modal patient-level data including clinical, imaging, and radiotherapy data from the US and EU to support AI model development and validation for a top-10 pharma company
• Harmonized imaging, clinical, radiotherapy, and HCRU data from more than 2,000 patients across the US and EU for a network of leading healthcare systems and cancer centers, enabling faster multi-modal analysis and scalable collaboration

BC Platforms meets the highest international standards for data protection, product quality, and ethical data governance through ISO-certified systems and compliance frameworks that protect every stage of the data lifecycle. With more than 25 years of experience, BC Platforms serves both healthcare organizations seeking to unlock the value of their data and life sciences companies requiring high-quality, diverse, harmonized real-world data to support clinical development, regulatory submissions, and commercial success.